Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women

Exemestane is an irreversible inhibitor of the aromatase enzyme, which is a key component in the production of estrogen. The majority of breast cancers are sensitive to the proliferative effects of estrogen. Exemestane is approved for the adjuvant treatment of postmenopausal women with breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kittaneh, Muaiad, Glück, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Expert Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201097/
https://www.ncbi.nlm.nih.gov/pubmed/22084574
http://dx.doi.org/10.4137/BCBCR.S6234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201097/
https://www.ncbi.nlm.nih.gov/pubmed/22084574
http://dx.doi.org/10.4137/BCBCR.S6234

Ejemplares similares